Skip to main content

Levinson Mitchell E.'s Form 4 filing

Pulse Biosciences, Inc. (PLSE) · filed Nov 17, 2023

Accession no.
0001437749-23-032408
Filed
Nov 17, 2023
Trade date
Nov 15, 2023
Filing delay
2 days
Rule 10b5-1 plan
Not checked

This filing lists 10 non-derivative transactions and 0 derivative transactions. Open-market purchases total $105.1K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Levinson Mitchell E.CIK 0001674465Officer (Chief Strategy Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Nov 15, 2023Common StockPPurchaseAcquired+461$5.83+$2,687.6369,227Direct
Nov 15, 2023Common StockPPurchaseAcquired+3,800$5.88+$22,34473,027Direct
Nov 15, 2023Common StockPPurchaseAcquired+5,000$5.94+$29,7009,135Indirect
Nov 15, 2023Common StockPPurchaseAcquired+200$5.92+$1,184934Indirect
Nov 15, 2023Common StockPPurchaseAcquired+2,300$5.94+$13,6623,234Indirect
Nov 15, 2023Common StockPPurchaseAcquired+100$5.94+$594834Indirect
Nov 15, 2023Common StockPPurchaseAcquired+2,400$5.85+$14,0403,234Indirect
Nov 15, 2023Common StockPPurchaseAcquired+100$5.90+$590834Indirect
Nov 15, 2023Common StockPPurchaseAcquired+2,400$5.80+$13,9203,234Indirect
Nov 15, 2023Common StockPPurchaseAcquired+1,039$6.13+$6,369.071,039Indirect

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)